October 17, 2013
The Federal Circuit on Wednesday affirmed a Florida federal judge's victory for Valeant Pharmaceuticals International Inc. in its patent dispute with Watson Pharmaceuticals Inc. over the antidepressant Aplenzin, a decision preserving Valeant's exclusivity over the drug.